- Santen Pharmaceutical Co., Ltd. has submitted the Premarket Approval (PMA) application for DE-128 (MicroShunt) for review.
- US FDA has accepted the application from Santen.
- DE-128 is an investigational surgical glaucoma implant.
The United States Food and Drug Administration (US FDA) has accepted the Premarket Approval (PMA) application from Santen Pharmaceuti....
Tags : United States Food and Drug Administration, USFDA, Santen Pharmaceutical Co. Ltd., DE-128, Premarket Approval, PMA, primary open-angle glaucoma, POAG ,